» Articles » PMID: 17900462

Association of Carotid Intima-medial Thickness and Indices of Arterial Stiffness with Cardiovascular Disease Outcomes in CKD

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2007 Sep 29
PMID 17900462
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Indices of arterial structure and stiffness are proposed as surrogate markers of cardiovascular disease in patients with chronic kidney disease (CKD), but no study examined multiple markers in the same population.

Study Design: Prospective observational study.

Setting & Participants: 315 subjects with stages 4 to 5 CKD, aged 24 to 79 years (mean age, 56.6 +/- 13.6 [SD] years), enrolled in the Atherosclerosis and Folic Acid Supplementation Trial.

Predictors: Carotid arterial intima-medial thickness (IMT; n = 315) and indices of arterial stiffness (n = 207), including aortofemoral pulse wave velocity (PWV[a-f]), systemic arterial compliance (SAC), and carotid-derived augmentation index.

Outcomes: The primary outcome was a composite of all fatal and nonfatal cardiovascular events.

Results: During follow-up (median, 3.6 years), 95 cardiovascular events occurred. On Cox proportional-hazard modeling, mean maximum IMT, PWV(a-f), and SAC were predictive of the composite clinical end point of all cardiovascular events, but carotid-derived augmentation index was not (hazard ratio [HR] for every 0.01-mm increase in IMT, 1.09; P = 0.001; 95% confidence interval [CI], 1.03 to 1.14; HR for every 1-m/s increase in PWV(a-f), 1.18; P < 0.001; 95% CI, 1.12 to 1.25; HR for every 0.01-U/mm Hg decrease in SAC, 0.98; P = 0.01; 95% CI, 0.97 to 0.99). After adjustment for age, sex, blood pressure, diabetes, past cardiovascular disease, cholesterol level, and smoking, PWV(a-f) remained a significant independent predictor of cardiovascular events (adjusted HR, 1.12; P = 0.001; 95% CI, 1.05 to 1.20), but IMT and SAC did not.

Limitations: Study power to analyze differences between predialysis and dialysis stages of CKD.

Conclusions: PWV(a-f) is the only arterial index independently associated with cardiovascular outcome in patients with CKD.

Citing Articles

Estimated Pulse Wave Velocity Is Associated With All-Cause Mortality and Cardiovascular Mortality Among Adults With Chronic Kidney Disease.

Feng X, Chen Y, Chen X, Zhao W J Clin Hypertens (Greenwich). 2025; 27(1):e14971.

PMID: 39853934 PMC: 11771810. DOI: 10.1111/jch.14971.


Osteoprotegerin and Vascular Dysfunction in Patients with Stage 3 Chronic Kidney Disease and Those without Renal Dysfunction: A Case-Control Study.

Matos T, Vitorino P, Orlow R, Melo A, Amorim D, Sousa G Arq Bras Cardiol. 2024; 121(11):e20240122.

PMID: 39607169 PMC: 11634311. DOI: 10.36660/abc.20240122.


Curcumin Supplementation and Vascular and Cognitive Function in Chronic Kidney Disease: A Randomized Controlled Trial.

Gimblet C, Kruse N, Geasland K, Michelson J, Sun M, Ten Eyck P Antioxidants (Basel). 2024; 13(8).

PMID: 39199229 PMC: 11352164. DOI: 10.3390/antiox13080983.


Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial.

Saadati S, Cameron J, Menon K, Hodge A, Lu Z, de Courten M Nutrients. 2023; 15(22).

PMID: 38004228 PMC: 10674211. DOI: 10.3390/nu15224835.


The effect of exercise on vascular health in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.

Davies M, Hughes F, Sandoo A, Alejmi A, Macdonald J Am J Physiol Renal Physiol. 2023; 325(5):F638-F655.

PMID: 37733834 PMC: 10881234. DOI: 10.1152/ajprenal.00152.2023.